SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Second tranche of share buyback programme

1 May 2026 07:00

RNS Number : 6884C
McBride PLC
01 May 2026
 

McBride plc

 

Second tranche of share buyback programme

 

McBride plc (the "Company"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning/hygiene markets, today announces the commencement of the second tranche of its share buyback programme to purchase ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as launched on 1 December 2025 (the "Programme").

Purchases under the first tranche of the Programme commenced on 1 December 2025 and continued until 30 April 2026. Under the first tranche, between 1 December 2025 and 30 April 2026, the Company repurchased 3,236,565 Ordinary Shares for an aggregate consideration of approximately £4.5 million.

The Company announces that the second tranche of the Programme of up to £15.5 million (being the balance of the £20 million maximum amount of the Programme less the aggregate consideration paid under the first tranche of the Programme) will commence today (the "Second Tranche"). The Second Tranche is structured in two phases. In respect of the first phase, the Company has entered into a non-discretionary agreement with Investec Bank plc ("Investec") to act as riskless principal in relation to the purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares to the Company. The second phase will be undertaken by Peel Hunt LLP ("Peel Hunt", together with Investec, the "Brokers"). The Company has entered into a non-discretionary agreement with Peel Hunt to act as riskless principal in relation to the purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares to the Company.

Purchases of Ordinary Shares under the Second Tranche are expected to commence on 1 May 2026 and to be completed by no later than 30 September 2026. The Company intends to announce any purchases under the Programme on a weekly basis from the commencement of the Second Tranche of the Programme.

The Brokers will each make trading decisions in relation to the Programme independently of the Company. Any purchase of Ordinary Shares by the Brokers contemplated by this announcement will be carried out on the London Stock Exchange. Any purchases of Ordinary Shares by the Company under the Programme will be carried out on the London Stock Exchange.

The purpose of the Programme is to reduce the share capital of the Company by returning surplus capital to shareholders. Ordinary Shares purchased under the Second Tranche will be cancelled. These arrangements are in accordance with the Company's general authority to repurchase up to 17,401,528 Ordinary Shares granted at its 2025 Annual General Meeting. The Second Tranche will also be conducted within certain pre-set parameters, in accordance with Chapter 9 of the Listing Rules and within the parameters prescribed by the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

From time to time, the Board will assess the progress of this Programme in light of the financial situation of the Company and its capital allocation needs.

For further information, please contact:

 

McBride plc

Via TEAM LEWIS

Chris Smith, Chief Executive Officer

Mark Strickland, Chief Financial Officer

TEAM LEWIS

McBride@teamlewis.com

Hannah Scott

Galyna Kulachek

+44 (0)20 7802 2634

+44 (0)20 7802 2617

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKKBPOBKDBQN
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.